Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.

Christenson RH, Peacock WF, Apple FS, Limkakeng AT Jr, Nowak RM, McCord J, deFilippi CR.

Contemp Clin Trials Commun. 2019 Feb 15;14:100337. doi: 10.1016/j.conctc.2019.100337. eCollection 2019 Jun.

2.

Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel.

Januzzi JL Jr, Mahler SA, Christenson RH, Rymer J, Newby LK, Body R, Morrow DA, Jaffe AS.

J Am Coll Cardiol. 2019 Mar 12;73(9):1059-1077. doi: 10.1016/j.jacc.2018.12.046. Epub 2019 Feb 21. Review.

PMID:
30798981
3.

Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study.

McCord J, Aurora L, Lindahl B, Giannitsis E, Calle-Muller C, Nowak R, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Crit Pathw Cardiol. 2019 Mar;18(1):10-15. doi: 10.1097/HPC.0000000000000163.

PMID:
30747759
4.

Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort.

Ayer A, Mills C, Donovan C, Christenson RH, Ganz P, Dubin RF.

Hemodial Int. 2019 Jan;23(1):58-68. doi: 10.1111/hdi.12675. Epub 2019 Feb 6.

PMID:
30724445
5.

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.

Ghorbani A, Bhambhani V, Christenson RH, Meijers WC, de Boer RA, Levy D, Larson MG, Ho JE.

J Am Coll Cardiol. 2018 Dec 25;72(25):3246-3254. doi: 10.1016/j.jacc.2018.09.076.

PMID:
30573026
6.

1-h Evaluation for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay.

Nowak RM, Gandolfo CM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

J Am Coll Cardiol. 2018 Nov 27;72(21):2677-2679. doi: 10.1016/j.jacc.2018.08.2190. No abstract available.

PMID:
30466528
7.

Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Vafaie M, Biener M, Haushofer AC, Seier J, Christ M, Alquézar-Arbé A, deFilippi CR, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French JK, Christenson RH, Dinkel C, Katus HA, Mueller C.

Int J Cardiol. 2019 Feb 1;276:261-267. doi: 10.1016/j.ijcard.2018.10.084. Epub 2018 Oct 26.

PMID:
30404726
8.

Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide.

Limkakeng AT Jr, Leahy JC, Griffin SM, Lokhnygina Y, Jaffa E, Christenson RH, Newby LK.

Open Heart. 2018 Oct 8;5(2):e000847. doi: 10.1136/openhrt-2018-000847. eCollection 2018.

9.

High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus.

Asrani P, Aly AM, Jiwani AK, Niebuhr BR, Christenson RH, Jain SK.

J Perinatol. 2018 Nov;38(11):1483-1489. doi: 10.1038/s41372-018-0192-x. Epub 2018 Aug 31.

PMID:
30171214
10.

Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults.

Michos ED, Mitchell CM, Miller ER 3rd, Sternberg AL, Juraschek SP, Schrack JA, Szanton SL, Walston JD, Kalyani RR, Plante TB, Christenson RH, Shade D, Tonascia J, Roth DL, Appel LJ; STURDY Collaborative Research Group.

Contemp Clin Trials. 2018 Oct;73:111-122. doi: 10.1016/j.cct.2018.08.004. Epub 2018 Aug 20.

PMID:
30138718
11.

Ultrarapid Rule-out for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay: Results From the REACTION-US Study.

Nowak RM, Gandolfo CM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

Ann Emerg Med. 2018 Dec;72(6):654-664. doi: 10.1016/j.annemergmed.2018.06.021. Epub 2018 Aug 14.

PMID:
30119942
12.

Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.

Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, Gunnar Brolinson P, Büki A, Chen JY, Christenson RH, Hack D, Huff JS, Johar S, Jordan JD, Leidel BA, Lindner T, Ludington E, Okonkwo DO, Ornato J, Peacock WF, Schmidt K, Tyndall JA, Vossough A, Jagoda AS.

Lancet Neurol. 2018 Sep;17(9):782-789. doi: 10.1016/S1474-4422(18)30231-X. Epub 2018 Jul 24.

PMID:
30054151
13.

Differentiating type 1 and 2 acute myocardial infarctions using the N-terminal pro B-type natriuretic peptide/cardiac troponin T ratio.

Nowak RM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

Am J Emerg Med. 2018 Oct;36(10):1849-1854. doi: 10.1016/j.ajem.2018.06.073. Epub 2018 Jul 2.

PMID:
30007549
14.

Corrigendum to 'Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay' [Clin. Biochem. 56 (2018) 4-10].

Christenson RH, Mullins K, Duh SH.

Clin Biochem. 2018 Aug;58:132. doi: 10.1016/j.clinbiochem.2018.06.008. No abstract available.

PMID:
29908760
15.

Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay.

Christenson RH, Mullins K, Duh SH.

Clin Biochem. 2018 Jun;56:4-10. doi: 10.1016/j.clinbiochem.2018.05.004. Epub 2018 May 9. Erratum in: Clin Biochem. 2018 Aug;58:132.

PMID:
29750939
16.

Copeptin to rule out myocardial infarction in Blacks versus Caucasians.

Beri N, Daniels LB, Jaffe A, Mueller C, Anand I, Peacock WF, Hollander JE, DeFilippi C, Schreiber D, McCord J, Limkakeng AT, Wu AHB, Apple FS, Diercks DB, Nagurney JT, Nowak RM, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Eur Heart J Acute Cardiovasc Care. 2018 May 1:2048872618772500. doi: 10.1177/2048872618772500. [Epub ahead of print]

PMID:
29737180
17.

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

Januzzi JL Jr, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Rivers EJ, Walters EL, Gaggin HK; ICON-RELOADED Investigators.

J Am Coll Cardiol. 2018 Mar 20;71(11):1191-1200. doi: 10.1016/j.jacc.2018.01.021.

18.

"Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).

Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, de Lemos JA, Neeland IJ, deFilippi CR.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e006619. doi: 10.1161/JAHA.117.006619.

19.

Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM.

Dig Dis Sci. 2018 Mar;63(3):665-675. doi: 10.1007/s10620-017-4897-z. Epub 2018 Feb 1.

21.

Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.

Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C.

Transl Res. 2018 May;195:25-47. doi: 10.1016/j.trsl.2017.12.002. Epub 2017 Dec 12.

PMID:
29291380
22.

Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction.

Hachey BJ, Kontos MC, Newby LK, Christenson RH, Peacock WF, Brewer KC, McCord J.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e005852. doi: 10.1161/JAHA.117.005852.

23.

Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.

Gaggin HK, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Walters EL, Januzzi JL; ICON-RELOADED Investigators.

Am Heart J. 2017 Oct;192:26-37. doi: 10.1016/j.ahj.2017.07.002. Epub 2017 Jul 8.

PMID:
28938961
24.
25.

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Appel LJ, Christenson RH, Sacks FM, Selvin E.

Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.

27.

Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay.

Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB.

Clin Chem. 2017 May;63(5):1043-1045. doi: 10.1373/clinchem.2017.271361. Epub 2017 Mar 21. No abstract available.

28.

Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.

Loomis SJ, Chen Y, Sacks DB, Christenson ES, Christenson RH, Rebholz CM, Selvin E.

Clin Chem. 2017 May;63(5):980-989. doi: 10.1373/clinchem.2016.264135. Epub 2017 Mar 9.

29.

Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.

McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, Frisoli T, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003101. doi: 10.1161/CIRCOUTCOMES.116.003101.

PMID:
28167641
30.

High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Seliger SL, Hong SN, Christenson RH, Kronmal R, Daniels LB, Lima JAC, de Lemos JA, Bertoni A, deFilippi CR.

Circulation. 2017 Apr 18;135(16):1494-1505. doi: 10.1161/CIRCULATIONAHA.116.025505. Epub 2017 Feb 3.

31.

Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM.

BMJ Open Diabetes Res Care. 2016 Nov 14;4(1):e000276. eCollection 2016.

32.

Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.

Mueller-Hennessen M, Mueller C, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Ordóñez-Llanos J, Panteghini M, Plebani M, Verschuren F, Melki D, French JK, Christenson RH, Body R, McCord J, Dinkel C, Katus HA, Lindahl B; TRAPID-AMI Investigators.

Clin Chem. 2017 Feb;63(2):542-551. doi: 10.1373/clinchem.2016.258392. Epub 2016 Dec 8.

33.

Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort.

DeFina LF, Willis BL, Radford NB, Christenson RH, deFilippi CR, de Lemos JA.

J Am Heart Assoc. 2016 Nov 28;5(12). pii: e003781.

34.

Necessity of hospitalization and stress testing in low risk chest pain patients.

Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Mueller C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AHB, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Am J Emerg Med. 2017 Feb;35(2):274-280. doi: 10.1016/j.ajem.2016.10.072. Epub 2016 Oct 29.

PMID:
27847253
35.

Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review.

Sandhu PK, Musaad SM, Remaley AT, Buehler SS, Strider S, Derzon JH, Vesper HW, Ranne A, Shaw CS, Christenson RH.

J Appl Lab Med. 2016 Sep 1;1(2):214-229. Epub 2016 Aug 1.

36.

Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay.

Palme S, Christenson RH, Jortani SA, Ostlund RE, Kolm R, Kopal G, Laubender RP.

Clin Biochem. 2017 Feb;50(3):139-144. doi: 10.1016/j.clinbiochem.2016.10.002. Epub 2016 Oct 8.

37.

Defining the Path Forward: Guidance for Laboratory Medicine Guidelines.

Kahn SE, Jones PM, Chin AC, Christenson RH.

EJIFCC. 2015 Aug 24;26(3):158-67. eCollection 2015 Aug.

38.

Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention.

deFilippi CR, de Lemos JA, Newman AB, Guralnik JM, Christenson RH, Pahor M, Church T, Espeland M, Krithevsky SB, Stafford R, Seliger SL; LIFE Study Group.

Am Heart J. 2016 Sep;179:151-6. doi: 10.1016/j.ahj.2016.07.001. Epub 2016 Jul 12.

PMID:
27595690
39.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

40.

Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.

McEvoy JW, Chen Y, Halushka MK, Christenson E, Ballantyne CM, Blumenthal RS, Christenson RH, Selvin E.

J Am Heart Assoc. 2016 May 13;5(5). pii: e003079. doi: 10.1161/JAHA.115.003079.

41.

The standards for reporting diagnostic accuracy studies 2015 update: is there a missing link to the triumvirate?

Wu AH, Christenson RH.

Ann Transl Med. 2016 Feb;4(3):44. doi: 10.3978/j.issn.2305-5839.2015.12.41. No abstract available.

42.

Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C; TRAPID-AMI Investigators.

Int J Cardiol. 2016 Apr 15;209:26-33. doi: 10.1016/j.ijcard.2016.01.213. Epub 2016 Feb 3.

PMID:
26878470
43.

Critical appraisal in the practice of laboratory medicine.

Price CP, Christenson RH.

Ann Clin Biochem. 2016 Mar;53(Pt 2):222-32. doi: 10.1177/0004563215599008. Epub 2015 Jul 17. Review.

PMID:
26187554
44.

Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.

Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA.

J Am Heart Assoc. 2015 Jul 6;4(7). pii: e001646. doi: 10.1161/JAHA.114.001646.

45.

Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.

Mindikoglu AL, Dowling TC, Schaub DJ, Hutson WR, Potosky DR, Christenson RH, Barth RN, LaMattina JC, Hanish SI, Weir MR, Raufman JP.

Dig Dis Sci. 2015 Nov;60(11):3491-4. doi: 10.1007/s10620-015-3771-0. Epub 2015 Jul 5. No abstract available.

46.

Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.

Mindikoglu AL, Dowling TC, Magder LS, Christenson RH, Weir MR, Seliger SL, Hutson WR, Howell CD.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):624-632.e2. doi: 10.1016/j.cgh.2015.06.021. Epub 2015 Jun 29.

47.

Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial.

Marston NA, Shah KS, Mueller C, Neath SX, Christenson RH, McCord J, Nowak RM, Daniels LB, Hollander JE, Apple F, Nagurney J, Schreiber D, deFilippi C, Diercks D, Limkakeng A, Anand IS, Wu AH, Jaffe AS, Peacock WF, Maisel AS.

Emerg Med J. 2016 Jan;33(1):23-9. doi: 10.1136/emermed-2015-204692. Epub 2015 Jun 23.

PMID:
26105583
48.

Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project.

Tate JR, Bunk DM, Christenson RH, Barth JH, Katrukha A, Noble JE, Schimmel H, Wang L, Panteghini M; IFCC Working Group on Standardization of Cardiac Troponin I.

Clin Chem Lab Med. 2015 Apr;53(5):677-90. doi: 10.1515/cclm-2014-1197.

49.

Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.

Shah KS, Marston NA, Mueller C, Neath SX, Christenson RH, McCord J, Nowak RM, Vilke GM, Daniels LB, Hollander JE, Apple FS, Cannon CM, Nagurney J, Schreiber D, deFilippi C, Hogan CJ, Diercks DB, Limkakeng A, Anand IS, Wu AH, Clopton P, Jaffe AS, Peacock WF, Maisel AS.

Acad Emerg Med. 2015 May;22(5):554-63. doi: 10.1111/acem.12649. Epub 2015 Apr 23.

50.

Evolving role of galectin-3 as a cardiac biomarker: heart failure with preserved ejection fraction and renal function, important pieces of the puzzle.

deFilippi CR, Christenson RH.

JACC Heart Fail. 2015 Mar;3(3):253-6. doi: 10.1016/j.jchf.2014.12.009. No abstract available.

Supplemental Content

Loading ...
Support Center